DELISHAJ, DURIM
 Distribuzione geografica
Continente #
NA - Nord America 1.031
EU - Europa 391
AS - Asia 113
AF - Africa 48
OC - Oceania 1
Totale 1.584
Nazione #
US - Stati Uniti d'America 1.012
IT - Italia 141
SE - Svezia 120
CN - Cina 63
BG - Bulgaria 39
DE - Germania 28
CI - Costa d'Avorio 23
SG - Singapore 22
AT - Austria 19
CA - Canada 17
GB - Regno Unito 17
VN - Vietnam 17
SN - Senegal 13
FR - Francia 12
FI - Finlandia 9
NG - Nigeria 9
HK - Hong Kong 6
IN - India 3
MG - Madagascar 3
RU - Federazione Russa 3
MX - Messico 2
PK - Pakistan 2
AU - Australia 1
BE - Belgio 1
CH - Svizzera 1
UA - Ucraina 1
Totale 1.584
Città #
Woodbridge 158
Fairfield 133
Chandler 114
Ann Arbor 78
Houston 66
Ashburn 62
Seattle 62
Cambridge 55
Wilmington 49
Sofia 39
Serra 38
Beijing 30
New York 26
Abidjan 23
Florence 19
Vienna 19
Ottawa 17
Lawrence 16
Princeton 16
Pisa 15
Medford 14
Dakar 13
Des Moines 12
Dong Ket 11
Lagos 9
Frankfurt am Main 8
London 8
Bremen 7
Dearborn 7
Massa E Cozzile 7
Detroit 6
Hong Kong 6
Lancaster 6
Nanjing 6
Redwood City 6
Zhengzhou 4
Antananarivo 3
Boulder 3
Falls Church 3
Indiana 3
Milan 3
San Diego 3
San Francisco 3
Shanghai 3
Siena 3
Genoa 2
Hebei 2
Hicksville 2
Jiaxing 2
Kunming 2
Marseille 2
Nürnberg 2
Phoenix 2
Shenyang 2
Taiyuan 2
Troina 2
Vicopisano 2
Bari 1
Brussels 1
Bryan 1
Böblingen 1
Capannori 1
Changchun 1
Changsha 1
Chehalis 1
Chengdu 1
Edinburgh 1
Erlangen 1
Islamabad 1
Jinan 1
Kilburn 1
Limeil-brévannes 1
Lucca 1
Nanchang 1
New Delhi 1
Norwalk 1
Ogden 1
Redmond 1
Royal Oak 1
St Louis 1
Sydney 1
Tambov 1
Taramani 1
Tianjin 1
Wenzhou 1
Totale 1.244
Nome #
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy 177
The effectiveness of bevacizumab in radionecrosis after radiosurgery of a single brain metastasis 157
Bevacizumab for the Treatment of Radiation-Induced Cerebral Necrosis: A Systematic Review of the Literature 146
Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? 134
Salvage Hypofractionated Radiotherapy in Combination with Bevacizumab in Patients with Recurrent High Grade Glioma: A Mono-institutional Experience 120
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy 114
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 109
Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis 107
Non-melanoma skin cancer treated with high-dose-rate brachytherapy: A review of literature 105
Set-up errors in head and neck cancer treated with IMRT technique assessed by cone-beam computed tomography: a feasible protocol 94
Role of perfusion CT in the evaluation of metastatic nodal tumor response after radiochemotherapy in head and neck cancer: preliminary findings 85
The role of clinicopathologic and molecular prognostic factors in the post-mastectomy radiotherapy (PMRT): a retrospective analysis of 912 patients 82
Concomitant external-beam irradiation and chemotherapy followed by high-dose rate brachytherapy boost in the treatment of squamous cell carcinoma of the vagina: A single-center retrospective study 62
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology 62
Clinical Outcomes of Stereotactic Body Radiotherapy in Oligometastatic Gynecological Cancer 61
Non-melanoma skin cancer treated with high-doserate brachytherapy and Valencia applicator in elderly patients: a retrospective case series 18
Integrating stereotactic radiotherapy and systemic therapies 2
Totale 1.635
Categoria #
all - tutte 4.174
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.174


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019127 0 0 0 0 0 0 0 0 0 27 50 50
2019/2020369 43 16 34 38 32 39 41 37 36 27 17 9
2020/2021123 6 15 5 1 10 11 11 10 16 17 2 19
2021/2022174 3 4 0 13 39 22 3 9 13 2 13 53
2022/2023379 41 68 34 20 39 38 3 24 73 0 33 6
2023/2024115 11 10 24 3 18 32 5 5 7 0 0 0
Totale 1.635